Michelle Taylor Selected Research

Michelle Taylor Research Topics

5	Substance-Related Disorders (Drug Abuse) 01/2019 - 08/2007
2	Neuroinflammatory Diseases 11/2021 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 05/2021 - 01/2021
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 01/2020
2	Tobacco Use Disorder (Nicotine Dependence) 01/2020 - 01/2017
2	Schizophrenia (Dementia Praecox) 01/2020 - 06/2011
1	Opiate Overdose 01/2022
1	Dyskinesias (Dyskinesia) 05/2021
1	Inflammation (Inflammations) 01/2021
1	COVID-19 10/2020
1	Autistic Disorder (Autism) 01/2020
1	Multiple Sclerosis 01/2020
1	Opioid-Related Disorders (Opiate Addiction) 11/2018
1	Antisocial Personality Disorder (Antisocial Personality) 12/2017
1	Hemolytic Anemia 01/2016
1	Thrombotic Thrombocytopenic Purpura 01/2016
1	Thrombotic Microangiopathies 01/2016
1	Movement Disorders (Movement Disorder) 01/2013
1	Bipolar Disorder (Manic Depressive Psychosis) 06/2011
1	Nervous System Diseases (Neurological Disorders) 03/2011
1	Dystonia (Limb Dystonia) 01/2011
1	Dystonic Disorders (Writer's Cramp) 01/2011
1	Oligohydramnios 04/2007
1	Birth Weight (Birth Weights) 04/2007
1	Fetal Weight 04/2007
1	Cocaine-Related Disorders (Cocaine Addiction) 02/2005

6	Dopamine Receptors (Dopamine Receptor)IBA 05/2021 - 01/2011
3	LigandsIBA 05/2021 - 08/2007
2	Illicit Drugs (Recreational Drugs)IBA 01/2017 - 01/2017
2	Dopamine D3 ReceptorsIBA 08/2014 - 08/2007
1	Naloxone (Narcan)FDA LinkGeneric 01/2022
1	Complement C3 (C3 Complement)IBA 11/2021
1	Levodopa (L Dopa)FDA LinkGeneric 05/2021
1	Oxidopamine (6 Hydroxydopamine)IBA 05/2021
1	ChemokinesIBA 01/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2020
1	ursodoxicoltaurineIBA 01/2020
1	Bile Acids and Salts (Bile Acids)IBA 01/2020
1	Cocaine (Cocaine HCl)IBA 01/2020
1	Heroin (Diamorphine)IBA 01/2020
1	SmokeIBA 01/2020
1	CalciumIBA 11/2018
1	Biological ProductsIBA 12/2017
1	thiamine triphosphorate (TTP)IBA 01/2016
1	1- ((5- methoxy- 1H- indol- 3- yl)methyl)- 4- (4- (methylthio)phenyl)piperidin- 4- olIBA 01/2013
1	Antidepressive Agents (Antidepressants)IBA 06/2011
1	Antipsychotic Agents (Antipsychotics)IBA 06/2011
1	Aripiprazole (Abilify)FDA Link 06/2011
1	SpiperoneIBA 01/2011
1	pyridineIBA 08/2007
1	N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)but- 2- enyl)- 4- pyridine- 2- ylbenzamideIBA 08/2007
1	cyclo(Arg-Pro) (CI 4)IBA 04/2007
1	Pharmaceutical PreparationsIBA 02/2005